Blood and erythrocytes of 50 healthy volunteers and 105 patients with different forms of hemoblastoses were investigated. 54 patients had acute phase, 51 patients--remission stage of disease. Essential differences in the activity of antioxidant enzymes (SOD, CAT, GSH-Px) were detected and compared with content of MDA and degree of anaemia. Acute phase had more significantly alteration of antioxidant defence: diverse changes of the activity of SOD and CAT, significantly inhibition of GSH-Px, the high level of MDA and increased degree of anaemia.
Download PDF:
Citation:
Kumerova A.O., Petukhov V.I., Shkesters A.P., Silova A.A., Letse A.G. (1996) Possibility of the use of erythrocyte antioxidant enzymes as indicators characterising the development of disease in patients with hemoblastoses. Voprosy Meditsinskoi Khimii, 42(2), 144-147.
Kumerova A.O. et al. Possibility of the use of erythrocyte antioxidant enzymes as indicators characterising the development of disease in patients with hemoblastoses // Voprosy Meditsinskoi Khimii. - 1996. - V. 42. -N 2. - P. 144-147.
Kumerova A.O. et al., "Possibility of the use of erythrocyte antioxidant enzymes as indicators characterising the development of disease in patients with hemoblastoses." Voprosy Meditsinskoi Khimii 42.2 (1996): 144-147.
Kumerova, A. O., Petukhov, V. I., Shkesters, A. P., Silova, A. A., Letse, A. G. (1996). Possibility of the use of erythrocyte antioxidant enzymes as indicators characterising the development of disease in patients with hemoblastoses. Voprosy Meditsinskoi Khimii, 42(2), 144-147.
References
Guttendge J.М.С. // Free Radic Res Commun - 1993 - Vol 19 - P 141-158. Scholar google search
Сметанина НС, Ковригина ЕС и др //Гематол и трансфузиол —1991 — N2 — С 30-41. Scholar google search
